Section Arrow
RNXT.NASDAQ
- RenovoRx
(Financial Status)
Quotes are at least 15-min delayed:2026/06/07 02:22 EDT
Regular Hours
Last
 0.872
-0.1034 (-10.60%)
Day High 
0.99 
Prev. Close
0.9754 
1-M High
0.99 
Volume 
326.05K 
Bid
0.875
Ask
0.8787
Day Low
0.87 
Open
0.97 
1-M Low
0.77 
Market Cap 
43.99M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.92 
20-SMA 0.88 
50-SMA 0.93 
52-W High 1.45 
52-W Low 0.7006 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.33/-0.15
Enterprise Value
44.10M
Balance Sheet
Book Value Per Share
0.25
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.12M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BCDABioCardia Inc.1.03+0.111+12.08%-- 
BGMSBio Green Med Solution Inc1.5+0.44+41.51%0.3PE
CMNDClearmind Medicine Inc.3.98+1.07+36.77%-- 
ADTXAditxt Inc.0.0621-0.0149-19.35%-- 
RXRXRecursion Pharmaceuticals3.315-0.485-12.76%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.